| Optimization of the preparation process for human serum albumin (HSA) nanoparticles K Langer, S Balthasar, V Vogel, N Dinauer, H Von Briesen, D Schubert International journal of pharmaceutics 257 (1-2), 169-180, 2003 | 949 | 2003 |
| Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly (butyl cyanoacrylate) nanoparticles A Bootz, V Vogel, D Schubert, J Kreuter European journal of pharmaceutics and biopharmaceutics 57 (2), 369-375, 2004 | 505 | 2004 |
| Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation K Langer, MG Anhorn, I Steinhauser, S Dreis, D Celebi, N Schrickel, ... International journal of pharmaceutics 347 (1-2), 109-117, 2008 | 299 | 2008 |
| Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage M Holzer, V Vogel, W Mäntele, D Schwartz, W Haase, K Langer European Journal of Pharmaceutics and Biopharmaceutics 72 (2), 428-437, 2009 | 171 | 2009 |
| Proteolytically-induced changes of secondary structural protein conformation of bovine serum albumin monitored by Fourier transform infrared (FT-IR) and UV-circular dichroism … G Güler, MM Vorob'ev, V Vogel, W Mäntele Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 161, 8-18, 2016 | 127 | 2016 |
| Structural evolution of C‐terminal domains in the p53 family HD Ou, F Löhr, V Vogel, W Mäntele, V Dötsch The EMBO journal 26 (14), 3463-3473, 2007 | 112 | 2007 |
| Morphology, size distribution, and aggregate structure of lipopolysaccharide and lipid A dispersions from enterobacterial origin W Richter, V Vogel, J Howe, F Steiniger, A Brauser, MHJ Koch, M Roessle, ... Innate immunity 17 (5), 427-438, 2011 | 91 | 2011 |
| A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural … J Binici, J Hartmann, J Herrmann, C Schreiber, S Beyer, G Güler, V Vogel, ... Journal of biological chemistry 288 (48), 34295-34303, 2013 | 60 | 2013 |
| Assessing the drug release from nanoparticles: Overcoming the shortcomings of dialysis by using novel optical techniques and a mathematical model L Xie, S Beyer, V Vogel, MG Wacker, W Mäntele International Journal of Pharmaceutics 488 (1-2), 108-119, 2015 | 59 | 2015 |
| Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity C Wichmann, Y Becker, L Chen-Wichmann, V Vogel, A Vojtkova, ... Blood, The Journal of the American Society of Hematology 116 (4), 603-613, 2010 | 55 | 2010 |
| Oligonucleotide–protamine–albumin nanoparticles: preparation, physical properties, and intracellular distribution V Vogel, D Lochmann, J Weyermann, G Mayer, C Tziatzios, ... Journal of controlled release 103 (1), 99-111, 2005 | 52 | 2005 |
| Analysis of the complex formation of heparin with protamine by light scattering and analytical ultracentrifugation: implications for blood coagulation management J Maurer, S Haselbach, O Klein, D Baykut, V Vogel, W Mäntele Journal of the American Chemical Society 133 (4), 1134-1140, 2011 | 51 | 2011 |
| Temperature imaging of laser-induced thermotherapy (LITT) by MRI: evaluation of different sequences in phantom B Bazrafshan, F Hübner, P Farshid, R Hammerstingl, J Paul, V Vogel, ... Lasers in medical science 29, 173-183, 2014 | 50 | 2014 |
| Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction G Mayer, V Vogel, J Weyermann, D Lochmann, JA Van Den Broek, ... Journal of Controlled Release 106 (1-2), 181-187, 2005 | 49 | 2005 |
| A comparison of two biorelevant in vitro drug release methods for nanotherapeutics based on advanced physiologically-based pharmacokinetic modelling F Jung, L Nothnagel, F Gao, M Thurn, V Vogel, MG Wacker European Journal of Pharmaceutics and Biopharmaceutics 127, 462-470, 2018 | 46 | 2018 |
| Characterization of serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy V Vogel, K Langer, S Balthasar, P Schuck, W Mächtle, W Haase, ... Analytical Ultracentrifugation VI, 31-36, 2002 | 46 | 2002 |
| A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation M Wacker, A Zensi, J Kufleitner, A Ruff, J Schütz, T Stockburger, ... International journal of pharmaceutics 414 (1-2), 225-232, 2011 | 45 | 2011 |
| Real time observation of proteolysis with Fourier transform infrared (FT-IR) and UV-circular dichroism spectroscopy: Watching a protease eat a protein G Güler, E Džafić, MM Vorob’ev, V Vogel, W Mäntele Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 79 (1 …, 2011 | 44 | 2011 |
| Metallo‐supramolecular micelles: Studies by analytical ultracentrifugation and electron microscopy V Vogel, JF Gohy, BGG Lohmeijer, JA Van Den Broek, W Haase, ... Journal of Polymer Science Part A: Polymer Chemistry 41 (20), 3159-3168, 2003 | 43 | 2003 |
| Characterizing a monotopic membrane enzyme. Biochemical, enzymatic and crystallization studies on Aquifex aeolicus sulfide: quinone oxidoreductase M Marcia, JD Langer, D Parcej, V Vogel, G Peng, H Michel Biochimica et Biophysica Acta (BBA)-Biomembranes 1798 (11), 2114-2123, 2010 | 41 | 2010 |
Prof. Dr. Werner MänteleProfessor für Biophysik, Johann Wolfgang Goethe-Universität Frankfurt am MainVerificeret mail på biophysik.uni-frankfurt.de